Suzhou ASTRABIO Co., Ltd.

【Background】 Alzheimer’s disease (AD) involves complex alterations in biological pathways, making comprehensive blood biomarkers crucial for accurate and earlier diagnosis. However, the cost-effectiv...

【Editor’s summary】： One of the major causes of neurodegeneration in patients with Parkinson’s disease (PD) is the intracellular accumulation of α-synuclein in neurons. Wu et al. investigated the m...

【Highlights】： ?Plasma markers (GFAP and NfL) and regional SUVRs of 18F-AV-1451 PET could distinguish patients with MCI from CN in two cohorts. ?Increased tau deposition in the amygdala and l...

【Introduction】： Frontotemporal dementia (FTD) is characterized by phenotypic and genetic heterogeneities. However, reports on the large Chinese FTD cohort are lacking. 【Meth...

【Aims】： Apply established cerebrospinal fluid (CSF) and serum biomarkers and novel combined indicators based on the amyloid/tau/neurodegeneration (ATN) framework to improve diagnostic and pr...

【Background】： Previous studies have demonstrated that early intervention was the best plan to inhibit the progression of Alzheimer’s disease (AD), which relied on the discovery of early diagnostic bi...

【Highlights】： ?P-tau217 correlates with brain atrophy and cognitive impairment in AD patients ?Antibody against p-tau217 attenuates pathology and neuronal loss in tauopathic mice ?P-tau217 antibody...

【PUBLIC SUMMARY】: - In-depth proteomics workflow for profiling paired cerebrospinal fluid (CSF) and serum proteomes. - Independent multicenter set combined with multiple methods for...